A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.


Updates from The Motley Fool

Latest updates on Agenus from Fool.com.  The Fool has written over 100 articles on Agenus.
3 Top Biotech Stocks Under $5

Shares of Geron Corporation, Rigel Pharmaceuticals Inc., and Agenus Inc. appear to be trading for...



Stock Performance

View Interactive AGEN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Agenus.
Current Price: $4.67
Prev Close: $4.66
Open: $4.69
Bid: $4.60
Ask: $4.62
Day's Range: $4.59 - $4.72
52wk Range: $3.20 - $6.12
Volume: 1,064,026
Avg Vol 1,021,485
Market Cap: $466M
P/E (ttm): -3.64
EPS (ttm): ($1.28)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Agenus.
CAPS Rating 2 out of 5
 
207 Outperform
84 Underperform
CAPS All Stars
 
33 Outperform
31 Underperform

How do you think Agenus will perform against the market?



You pick for Agenus is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Garo H. Armen, CEO

56% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Agenus.

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers